🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07804706
Recruiting Observational

Preoperative Neutrophil-to-Albumin Ratio and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery

NCT07804706 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-09-09

Condition(s) studied

Hemodynamic InstabilityPost-induction Hypotension (PIH)

Study summary

This prospective observational study aims to evaluate whether the preoperative neutrophil percentage-to-albumin ratio (NPAR) is associated with post-induction hemodynamic vulnerability in adult patients undergoing elective major oncologic surgery under general anesthesia.

NPAR will be calculated from routine preoperative laboratory results by dividing the neutrophil percentage by the serum albumin level. No additional laboratory tests, medications, invasive procedures, or changes in anesthesia management will be performed for the purposes of the study.

Demographic characteristics, preoperative laboratory values, anesthetic data, and hemodynamic measurements will be recorded prospectively. Hemodynamic status will be evaluated during the period between induction of general anesthesia and surgical incision, with a maximum observation period of 20 minutes. Vasopressor use and administered doses will also be recorded.

The study will assess the ability of preoperative NPAR to identify patients who may be more susceptible to early hemodynamic instability following induction of general anesthesia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Scheduled for elective major oncologic surgery * Undergoing surgery under general anesthesia * Availability of preoperative complete blood count and serum albumin -measurements * Standard hemodynamic monitoring * Provision of written informed consent for participation in the study Exclusion Criteria: * Age younger than 18 years * Emergency surgery * Preoperative hemodynamic instability * Preoperative vasopressor or inotropic support * Sepsis or active infection * Hematologic malignancy * Advanced cardiac, renal, or hepatic failure * Pregnancy * Missing preoperative laboratory data -Inability to complete the 20-minute post-induction evaluation period-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital Ankara Yeni̇mahalle Recruiting

More Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07804706 on ClinicalTrials.gov ↗ ← All trials in Turkey